Skip to content

Stellate Ganglion Block in Longstanding Facial Nerve Palsy Patients

Stellate Ganglion Block in Longstanding Facial Nerve Palsy Patients

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06742255
Enrollment
34
Registered
2024-12-19
Start date
2024-12-20
Completion date
2024-12-20
Last updated
2024-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial Palsy, Pain Management, Stellate Ganglion

Keywords

Stellate gangliom, Facial palsy

Brief summary

The goal of the present study is to verify the efficacy of stellate ganglion block (SGB) in the treatment of facial pain

Interventions

DRUGStellate Ganglion Block

Stellate ganglion block is an injection of local anesthetic at the level of the neck to target the stellate ganglion, a sympathetic ganglion to interrupt abnormal autonomically-mediated pain in patients resistant to medical treatment

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* facial nerve palsy patients

Exclusion criteria

1. light of a recent myocardial infarction. 2. anticoagulant use 3. glucoma 4. lateral nerve palsy 5. emphysema 6. cardiac conduction abnormalities 7. active infection, flu, cold 8. uncontrolled cough 9. Fever 10. Very high blood pressure or if you are on blood thinners. 11. allergic reaction to local anesthetics 12. Primary and secondary coagulopathy.

Design outcomes

Primary

MeasureTime frame
Primary outcome: Average motor conduction latency in six muscle of the face6 month

Secondary

MeasureTime frameDescription
Improved muscle tone6 monthsfacial muscles start to regain their strength improvement of muscle tone.

Contacts

Primary ContactRemonda Zaki Abd El Naeem
mondazaki1996@gmai.com+201200184996

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026